 Pacer Advisors Inc. bought a new stake in Charles River Laboratories Intl. Inc NYSE:CRL during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities Exchange Commission. The institutional investor bought 11,400 shares of the medical research companys stock, valued at approximately 2,582,000. A number of other ... 